灵芝羊毛甾烷型三萜抗肿瘤构效关系初探

多篇文献报道灵芝三萜具有良好的抗肿瘤活性,但其构效关系和作用靶点尚未系统比较。本研究以45种灵芝三萜为研究对象,通过对小鼠白血病细胞L1210的增殖抑制测定,来评价化合物抗肿瘤的能力。结果表明,灵芝菌丝体三萜和子实体中性三萜的活性较强。进一步采用Discovery Studio分子对接技术探讨了12种活性较强的灵芝三萜与5种抗肿瘤作用相关蛋白p53、Bcl-xl、EGFR、IL-2和VEGFR2之间可能的作用靶点,推测三萜化合物抗肿瘤能力与其结构上的乙酰氧基和母环上的共轭双键有关。其中,具有这一特征的含有3个乙酰氧基的ganoderic acid T,其抗肿瘤活性最强。本研究为灵芝三萜活性位点的寻找和结构改造提供了参考。     

灵芝菌丝体三萜及其药理活性的研究进展

菌丝体作为灵芝生长发育过程中的一个特定生理阶段,会产生不同于子实体和孢子的特定结构的灵芝酸类三萜化合物。本文总结了灵芝菌丝体中已发现和鉴定的三萜化合物结构、生物活性及其构效关系的研究进展,以期为灵芝菌丝体三萜在生物合成、代谢调控等的基础研究及相关产品的开发应用提供科学参考。     

Ganoderma lucidum polysaccharide reduces melanogenesis by inhibiting the paracrine effects of keratinocytes and fibroblasts via IL-6/STAT3/FGF2 pathway

Our previous study found that Ganoderma lucidum polysaccharide (GLP), bioactive ingredients from Ganoderma lucidum, protected fibroblasts from photoaging. However, whether GLP can affect melanogenesis in melanocytes through regulating paracrine mediators that secreted by keratinocytes and fibroblasts is unclear. We aimed to investigate the efficacy and mechanisms of action of GLP in melanogenesis by regulating paracrine effects of keratinocytes and fibroblasts. The effect of GLP on cell viability affected by GLP was measured by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. After an immortal keratinocyte line (HaCaT) and primary fibroblasts (FB) were treated with GLP, the supernatants of HaCaT and FB cells were collected and cocultured with an immortalized melanocyte line (PIG1). The expression levels of melanogenesis-associated genes in PIG1 cells were measured by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot analysis. Furthermore, FRS-2, ERK, JNK, and p38 phosphorylation levels were measured. Then, major melanogenic paracrine mediators in HaCaT and FB cells treated with GLP were evaluated by qRT-PCR and enzyme-linked immunosorbent assay (ELISA). In addition, the expression of IL-6 and STAT3 was examined in HaCaT and FB cells. GLP was not cytotoxic to HaCaT and FB cells. The supernatants of GLP-treated HaCaT and FB cells downregulated the expression levels of MITF, TYR, TYRP1, TYRP2, RAB27A, and FSCN1 genes and inhibited the phosphorylation of FRS-2, ERK, JNK, and p38 in PIG1 cells. GLP also decreased FGF2 secretion in HaCaT and FB cells. Moreover, GLP reduced IL-6 expression and STAT3 phosphorylation in HaCaT and FB cells. GLP reduced melanogenesis in melanocytes by inhibiting the paracrine effects of keratinocytes and fibroblasts via IL-6/STAT3/FGF2 pathway.     

Effects of different graphene-based nanomaterials as elicitors on growth and ganoderic acid production by Ganoderma lucidum

Graphene-based nanomaterials (GBNs) have attracted considerable interest nowadays due to their wide range of applications. However, very little attention has been paid to the application of nanomaterials as potential elicitors for production of valuable metabolites. Herein, aiming to earn insight into effects of nanomaterials on secondary metabolite biosynthesis by medicinal fungi, we evaluated the influence of GBNs on growth and production of ganoderic acid (GA) by Ganoderma lucidum in submerged culture. Graphene oxide (GO), reduced graphene oxide (rGO), and rGO/Fe₃O₄ nanocomposite were synthesized successfully and characterized by X-ray diffraction, Fourier transform infrared spectroscopy, and scanning electron microscopy analysis. The prepared nanomaterials were added to the culture of G. lucidum at final concentrations of 50, 100, and 150 mg/L on Day 5. The results showed that the elicitation of G. lucidum with GO and rGO decreased the cell dry weight and GA production slightly, especially in higher concentrations. However, rGO/Fe₃O₄ nanocomposite not negatively affected cell growth and improved GA production. G. lucidum growth rate responded to elicitation experiments differently and depended on the type of nanomaterials and their concentrations, but almost all GBNs caused an increase in GA content (mg/100 mg dry weight). Also, field emission scanning electron microscopy morphological study showed that under elicitation, mycelia were more condensed and tightly stacked together. The findings from this study may suggest that GBNs in low concentrations could be applied as elicitors to secondary metabolites production from higher fungus, but further environmental, physiological, and biological studies required.     

灵芝孢子粉中脂溶性成分分析方法的建立

运用高效液相建立灵芝孢子粉中脂溶性成分的分析测定方法。通过色谱柱、洗脱条件、ELSD参数的优化,建立了12种脂溶性成分的测定方法,结果表明,该方法简单、准确、稳定,可以实现孢子粉中甘油三酯、脂肪酸、甾醇三类脂溶性成分的同时提取、分析;破壁孢子粉中脂溶性成分为301.49-397.37mg/g,孢子油产品中脂溶性成分的含量为626.00-713.07mg/g,远高于三萜含量;1,2-二油酸-3-棕榈酸甘油酯、甘油三油酸酯、1,2-二油酸-3-亚油酸甘油酯是主要的脂溶性成分,脂肪酸以不饱和脂肪酸亚油酸及油酸为主,甾醇中麦角甾醇含量最高。研究结果明确了灵芝孢子粉中脂溶性成分的物质基础,为深入研究其活性成分、全面评价孢子粉质量提供了依据。     

两种灵芝孢子粉多糖的分离纯化和结构

本文采用水提醇沉法从灵芝孢子粉中提取其粗多糖,经Sepharose CL-6B凝胶柱层析分离得两种主要成分LBPI和LBPII,经高效液相色谱鉴定,均为高均一性成分,分子量分别为9.17×10 ⁴和1.86×10 ⁴;经酸水解、乙酰化和气相色谱分析,确定LBPI的单糖组成为甘露糖、半乳糖和葡萄糖,LBPII的单糖组成为鼠李糖、甘露糖、半乳糖和葡萄糖;通过高碘酸氧化、甲基化和GC-MS进行结构分析,确定LBPI中葡萄糖残基连接方式为1→、1→4,6和1→3,6连接,半乳糖残基为1→6连接,甘露糖残基为1→3,6连接,LBPII中鼠李糖残基连接方式为1→连接,葡萄糖残基为1→、1→4、1→6、1→4,6和1→3,6连接,半乳糖残基为1→6连接,甘露糖残基为1→2,3,6连接。综上,两种多糖LBPI和LBPII均为多分支的中型杂多糖,但两者的单糖组成和连接方式存在差异,这两种多糖成分均为首次报道,可望为灵芝孢子粉的成分、活性研究和资源开发提供理论依据。     

灵芝钙调蛋白基因CaM的克隆与功能分析

灵芝是我国传统的食药用真菌,具有广泛的免疫调节功能并含有多种生物活性成分。灵芝酸是灵芝的主要次生代谢产物之一,具有较高商业价值。钙调蛋白（calmodulin,CaM）作为真核生物中重要的Ca ²⁺信使,能够参与生长发育、次生代谢等重要生理过程。本研究通过序列分析发现,灵芝CaM基因序列编码149个氨基酸,与其他物种CaM蛋白高度保守。该蛋白含有4个完整的EF-hand结构域,并且在每个EF-hand结构域中,都含有一个保守的D-x-D基序。进一步构建筛选了灵芝CaM沉默转化子,检测CaM在灵芝生长发育及次生代谢过程中的功能。结果显示,CaM沉默转化子中灵芝酸含量比WT降低约34%。沉默CaM后菌丝生长速率与WT相比降低40%。该结果说明CaM在灵芝生长及次生代谢过程中具有重要作用,为在真菌中研究CaM功能及调控途径提供参考。     

HPLC法测定灵芝孢子粉中三萜含量

为准确测定灵芝孢子粉中三萜的含量,运用高效液相建立适合孢子粉的分析测定方法。通过对前处理条件的优化,确定40%乙醇为孢子粉中等极性三萜酸类的最佳提取溶剂,浓缩倍数是子实体提取条件的50倍。通过色谱柱和洗脱条件的优化,建立了包括灵芝酸I、灵芝烯酸C、灵芝酸C2等13种标准品测定方法,方法学考察显示该分析方法精密度、重复性、稳定性的RSD值均小于5%,可以用于灵芝孢子粉中三萜类成分的定量检测。通过5组样品的分析发现,灵芝酸C6、灵芝酸G、灵芝酸A、灵芝酸D、灵芝酸F是灵芝孢子粉中的主要三萜类成分,其中灵芝酸A含量最高,平均占样品三萜总量的比例达19.71%;三萜类成分的溶出量与是否破壁没有相关性。三萜类成分在灵芝孢子粉和灵芝孢子油产品中的含量非常低,孢子粉的三萜含量为14.24-99.70μg/g,仅为子实体的1/100,灵芝孢子油中三萜含量也均低于50μg/g,因此三萜类成分不适合作为灵芝孢子粉及其相关产品的定量检测指标。     

Optimization of the fermentation parameters for the production of Ganoderma lucidum immunomodulatory protein by Pichia pastoris

Abstract

In order to obtain a better fermentation parameter for the production of recombinant Ganoderma lucidum immunomodulatory protein (rFIP-glu), an engineered Pichia pastoris GS115 was investigated on the fermentation time, temperature, methanol concentration and initial pH of media, while immunomodulatory activities of the rFIP-glu was confirmed. L₉(3³) orthogonal experiment were firstly employed to optimize various fermentation parameters in the shake-flask level. The optimized fermentation parameters were subsequently verified in a 5?L fermenter. Biological activities including cell viability and tumor necrosis factor-alpha (TNF-α) mRNA of the rFIP-glu were evaluated on murine macrophage RAW264.7 cells. The results showed that the yield of rFIP-glu was up to 368.71?μg/ml in the shake-flask, and 613.47?μg/ml in the 5?L fermenter, when the Pichia pastoris was incubated in basic media with the methanol concentration 1.0% and initial pH 6.5, and with constant shaking at 280?rpm for 4?days at 26?°C. In vitro assays of biological activity indicated that rFIP-glu had significant toxicity against RAW264.7 cells, and possessed the ability to induce TNF-α mRNA expression in macrophage RAW264.7 cells. In conclusion, engineered P. pastoris showed a good fermentation property under the optimum fermentation parameters. It could be a candidate industrial strain for further study.     

Ganoderma atrum polysaccharide induces anti-tumor activity via the mitochondrial apoptotic pathway related to activation of host immune response

Ganoderma atrum polysaccharide (PSG-1), the major active ingredient isolated from Ganoderma atrum, has been suggested as a candidate for cancer therapy. The aim of this study was to investigate the anti-tumor effect of PSG-1 using sarcoma 180 (S-180) transplanted mice and further to examine the molecular mechanisms of PSG-1-induced anti-tumor effect. Results showed that PSG-1 significantly inhibited tumor growth in S-180-bearing mice. PSG-1-induced tumor apoptosis was associated with the alteration of Bcl-2 family proteins, increase of reactive oxygen species generation, loss of mitochondrial membrane potential (Δψ(m) ), release of cytochrome c from the mitochondria into cytosol, and activation of caspase-3 and -9. Elevation of immune function was also shown during PSG-1-induced tumor apoptosis, as evidenced by increase of spleen and thymus indexes, lymphocyte proliferation, concentrations of tumor necrosis factor (TNF)-α, and interleukin-2 in serum. Furthermore, the combined treatment of PSG-1 and cyclophosphamide (CTX) results in an enhancement of the anti-tumor effect of CTX alone via increased host immune response. These results suggested that PSG-1 had a potent anti-tumor activity by induction of tumor apoptosis through mitochondrial pathways, and immunoenhancement effect of PSG-1 was related to its anti-tumor effect. In addition, PSG-1 enhanced CTX-induced anti-tumor activity in S-180-bearing mice.